Baird Medical Investment Holdings (BDMD) Non-Current Debt (2023 - 2025)
Baird Medical Investment Holdings' (BDMD) quarterly Non-Current Debt came in at $6.1 million in Q4 2025, up 76.8% year-on-year from $3.4 million in Q4 2024, and up 4.68% on a QoQ basis from $5.8 million in Q2 2025.
Baird Medical Investment Holdings (BDMD) Non-Current Debt (2023 - 2025) Analysis & Trends
Baird Medical Investment Holdings (BDMD) has 3 years of Non-Current Debt data on file, last reported at $6.1 million in Q4 2025.
- On a quarterly basis, Non-Current Debt rose 76.8% year-over-year to $6.1 million in Q4 2025; TTM through Dec 2025 was $6.1 million, a 76.8% increase from a year earlier, with the FY2025 full-year figure at $6.1 million, up 76.8% from the prior year.
- Non-Current Debt for Q4 2025 stood at $6.1 million, up from $5.8 million in the prior quarter.
- Over the last five years, Non-Current Debt for BDMD reached as high as $6.1 million in Q4 2025 and fell as low as $1.6 million in Q4 2023.
- Historically, Non-Current Debt has averaged $4.2 million across 3 years, with a median of $4.6 million in 2024.
- Across the five-year window, Non-Current Debt jumped 113.35% in 2024 and surged 76.8% in 2025, its largest moves.
- Year by year, Non-Current Debt stood at $1.6 million in 2023, then jumped by 113.35% to $3.4 million in 2024, then jumped by 76.8% to $6.1 million in 2025.
- Per Business Quant data, the three most recent Non-Current Debt figures were $6.1 million in Q4 2025, $5.8 million in Q2 2025, and $3.4 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.18 Bn |
| 10 | Baird Medical Investment Holdings | 30.57 Mn | 30.04 Mn | - | 6.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.09 Mn |
| Jun 30, 2025 | 5.81 Mn |
| Dec 31, 2024 | 3.44 Mn |
| Dec 31, 2023 | 1.61 Mn |